Echelon Biosciences Inc.
SEARCH






ASSAYS AND REAGENTS FOR DRUG DISCOVERY IN LIPID SIGNALING PATHWAYS
FORUMS
PRODUCT CATEGORIES
Antibodies and Lipid Recognition Proteins
Assays
Enzymes
Heme Pathway
Inhibitors
Inositol Phosphates
Intracellular Lipid Delivery Systems
Isoprenoids
Lipid-Protein Interaction Tools
Lipids
Lysophospholipid Products
MEP Pathway intermediates
Phosphoinositide Reagents and Derivatives
Phospholipase Substrates
Protein Kinases & Phosphatases
Sphingolipid Products
PURCHASE ASSISTANCE
Order Status
My Quotation
My Account
DISTRIBUTORS
TECHNICAL SUPPORT / FAQ
NEWS
TECHNICAL DATA SHEETS &     PROTOCOLS
PUBLICATIONS
BROWSE BY PATHWAY
FEEDBACK
SUBMIT PRODUCT IDEAS
Direct:801-588-0455
Fax:801-588-0497
       Category : Enzymes :   Protein Kinase : DDR2, active (20-390-540-29)
     Category : Protein Kinases & Phosphatases :   Kinases : DDR2, active (20-390-540-29)

20-390-540-29

Click to enlarge

Product Name

Catalog Number

Unit Price


Recombinant human DDR2 (467-end) was expressed by baculovirus in Sf 9 insect cells using a N-terminal GST
The gene accession number is NM_006182.
This material is sold for research purposes only.
Scientific Background:
—DDR2 is a member of a novel subclass of RTKs containing a distinct extracellular region encompassing a factor VIII-like domain (1) and is thought to be involved in the regulation of cell growth, differentiation, and metabolism. DDR2 plays a role in the regulation of collagen turnover mediated by smooth muscle cells in obstructive diseases of blood vessels and the lung (2).
Storage:
—Store product frozen at or below -70°C. Stable for 1 year at -70°C as undiluted stock. Aliquot to avoid repeated thawing and freezing.
References:
—1. Karn, T. et al: Structure, expression and chromosomal mapping of TKT from man and mouse: a new subclass of receptor tyrosine kinases with a factor VIII-like domain. Oncogene 8: 3433-3440, 1993.
2. Ferri, N. et al: Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis. Am J Pathol. 2004 May; 164(5): 1575-85.
 
Additional Informaiton
  --
E-K072G